Drug Type Small molecule drug |
Synonyms 6β-Bromopenicillanic acid, BRL 25214, BRL-25214 |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H10BrNO3S |
InChIKeyDAVPSCAAXXVSFU-ALEPSDHESA-N |
CAS Registry26631-90-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Phase 1 | Denmark | - | - |
Bacterial Infections | Phase 1 | United Kingdom | - | - |
Bacterial Infections | Phase 1 | - | - |